CD34 and laryngotracheoesophageal cleft: Surprisingly, contrary to the findings of the present study, a recent investigation [25] demonstrated a higher circulating level of EPCs (i.e. triple staining of the surface EPC marker: CD34/KDR/AC133) in patients with HCC than in those with LC.